• SALIENT FEATURES

    Paid patient days (PPDs)
    +2.7%

    Revenue
    +10.9% to R7 860 million

  • Normalised EBITDA
    +9% to R2 099 million

    Interim dividend of 73 cents per share
    +7.4%

    Normalised earnings per share increased to 87.1 cents
    +8.6%